DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.
Olsen TK, Dyberg C, Embaie BT, Alchahin A, Milosevic J, Ding J, Otte J, Tümmler C, Hed Myrberg I, Westerhout EM, Koster J, Versteeg R, Ding HF, Kogner P, Johnsen JI, Sykes DB, Baryawno N.
Olsen TK, et al. Among authors: hed myrberg i.
JCI Insight. 2022 Aug 9;7(17):e153836. doi: 10.1172/jci.insight.153836.
JCI Insight. 2022.
PMID: 35943801
Free PMC article.